(Q36739198)

16 August 2017

1 reference

title

Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age. (English)

1 reference

polycystic ovary syndrome

16 August 2017

0 references

1 reference

1 reference

Renato Pasquali

1

1 reference

PubMed ID

17308142

16 August 2017

Alessandra Gambineri

series ordinal

2

1 reference

PubMed ID

17308142

16 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Annals of the New York Academy of Sciences

16 August 2017

1 reference

16 August 2017

1092

1 reference

16 August 2017

158-174

1 reference

Polycystic Ovary Syndrome

16 August 2017

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Anovulation after precocious pubarche: early markers and time course in adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Polycystic ovary syndrome in adolescents: pathophysiology and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Obesity and reproductive disorders in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Effects of recombinant leptin therapy in a child with congenital leptin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Polycystic ovary syndrome and cardiovascular disease: a premature association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Polycystic ovaries in pre and post-menopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Obesity and the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

Fetal growth, length of gestation, and polycystic ovaries in adult life

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.014

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1365.014

1 reference

16 August 2017

1 reference

PubMed ID

17308142